CollPlant Biotechnologies Files June 2025 6-K Report
Ticker: CLGN · Form: 6-K · Filed: Jun 2, 2025 · CIK: 1631487
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
CollPlant filed its June 6-K, standard foreign issuer report.
AI Summary
CollPlant Biotechnologies Ltd. filed a Form 6-K on June 2, 2025, reporting on its activities for the month of June 2025. The filing is a report of a foreign private issuer and is incorporated by reference into the registrant's registration statements. The company is based in Rehovot, Israel.
Why It Matters
This filing provides routine updates for investors and stakeholders regarding the company's ongoing operations and compliance as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain material new financial information or strategic changes.
Key Players & Entities
- CollPlant Biotechnologies Ltd. (company) — Registrant
- 001-38370 (dollar_amount) — Commission File Number
- June 2, 2025 (date) — Filing Date
FAQ
What type of filing is this for CollPlant Biotechnologies Ltd.?
This is a Form 6-K, a Report of Foreign Private Issuer.
When was this Form 6-K filed?
The filing was made on June 2, 2025.
What is the Commission File Number for CollPlant Biotechnologies Ltd.?
The Commission File Number is 001-38370.
Where is CollPlant Biotechnologies Ltd. located?
The company's principal executive office is located at 4 Oppenheimer St, Weizmann Science Park Rehovot 7670104, Israel.
Does CollPlant Biotechnologies Ltd. file annual reports under Form 20-F or 40-F?
CollPlant Biotechnologies Ltd. files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding CollPlant Biotechnologies Ltd (CLGN).